Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 5 for:    "Acth-Secreting Pituitary Adenoma" | "glucocorticoids"

Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition (TICSI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03111810
Recruitment Status : Unknown
Verified October 2017 by University of Oxford.
Recruitment status was:  Recruiting
First Posted : April 13, 2017
Last Update Posted : October 6, 2017
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : January 2019
Publications: